Impact of rhythm control in wild-type transthyretin cardiac amyloidosis and atrial fibrillation: a retrospective analysis

Back

ESC2025 Premium Access

Impact of rhythm control in wild-type transthyretin cardiac amyloidosis and atrial fibrillation: a retrospective analysis

Session: Novel treatment approaches in heart failure and cardiomyopathies

Topic: Heart Failure with Preserved Ejection Fraction (HFpEF)

Speaker: Doctor J. Vogel (Essen, DE)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Julia Kirsten Vogel

University of Duisburg-Essen - West-German Heart and Vascular Center, Essen (Germany)

1 follower

6 more presentations in this session

Clinical features of chronic active myocarditis in patients with heart failure and reduced left ventricular ejection fraction

Speaker: Doctor M. Ruiz Cano (Bad Oeynhausen, DE)

Apical sparing and clinical parameters in patients with histologically confirmed transthyretin amyloidosis

Speaker: Mr T. Krammer (Regensburg, DE)

Impact of GDMT implementation on albuminuria in HFrEF

Speaker: Doctor N. Panagiotides (Vienna, AT)

Impact of tafamidis on sleep-disordered breathing in transthyretin cardiomyopathy

Speaker: Miss Y. Ferrari Chen (Pisa, IT)

Effects of sacubitril/valsartan in patients with heart failure with reduced ejection fraction and an eGFR below 30 ml/min/1.73 m2

Speaker: Ms J. Locatelli Bet (Rio Do Sul, BR)

Access the full session

Novel treatment approaches in heart failure and cardiomyopathies

Speakers: Doctor J. Vogel, Doctor M. Ruiz Cano, Mr T. Krammer, Doctor N. Panagiotides, Miss Y. Ferrari Chen...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources